Menopause Hormone Therapy (HRT) in Wilmington, DE

Bioidentical hormones in Wilmington: what it means

Behind the label "bioidentical hormone replacement therapy" is a plain idea: a hormone whose structure matches the body's own. Estradiol and micronized progesterone are both bioidentical: their structure matches the hormones the ovaries make. Neither has to be compounded: FDA-approved estradiol comes as pills, patches, gels, sprays, vaginal creams and rings, and progesterone as capsules.

Compounded hormones are a different thing: a pharmacy prepares them for one patient, as a cream, a capsule or a pellet. Compounded drugs are not FDA-approved, so the FDA cannot assure their safety, effectiveness or dose. In the FDA's words, it has no evidence that compounded "bioidentical hormones" are safe and effective. When the National Academies reviewed them in 2020, the evidence was mostly low quality, such as anecdotes and patient reports.

Through VevaMD, a physician licensed in Delaware decides whether hormone therapy fits you and, if so, the form: an estradiol pill, patch, cream or vaginal cream, with progesterone if you have a uterus. Pellets are not part of it. Because the dispensing pharmacy also compounds, you can ask whether your estradiol or progesterone is an FDA-approved product. Two options are compounded for certain: testosterone cream for women and Bi-Est are not FDA-approved.

The NPI registry counts 36 OB-GYNs practicing in Wilmington, about 50.6 for every 100,000 residents against 17.8 nationally and above Delaware's 19.1, a higher rate than 86% of the cities VevaMD covers. That is about 270 women aged 45 to 64 for each OB-GYN in the city, a ratio rather than a count of open appointments.

Counting the area around it, 43 OB-GYNs practice in Wilmington or within 10 miles and 685 within 25 miles: 27.2 for every 100,000 of the 2,514,013 people who live within 25 miles, a dense supply. Whether or not you have an OB-GYN, you can ask a physician licensed in Delaware about menopause hormone therapy online from Wilmington, with no waiting room.

Then there are pellets, implanted under the skin at a clinic; compounded pellets are not FDA-approved. The Endocrine Society points to a study that found hormone levels well above the expected range in women using them. ACOG recommends FDA-approved menopause hormone therapy over compounded hormones.

Sources: FDA: Menopause · FDA: National Academies study of compounded bioidentical hormones (2020) · Endocrine Society position statement on compounded bioidentical hormones (2019) · ACOG Clinical Consensus No. 6, compounded bioidentical menopausal hormone therapy (2023) · CMS NPPES NPI full file, 2026-10-11